Open AccessRates of Response to Atogepant for Migraine Prophylaxis Among Adults
Author(s) -
Richard B. Lipton,
Patricia PozoRosich,
Andrew Blumenfeld,
David W. Dodick,
Peter McAllister,
Ye Li,
Kaifeng Lu,
Brett Dabruzzo,
Rosa Miceli,
Lawrence Severt,
Michelle Finnegan,
Joel M. Trugman
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.15499
Subject(s) - migraine , medicine , placebo , clinical endpoint , chronic migraine , population , randomized controlled trial , clinical trial , calcitonin gene related peptide , anesthesia , receptor , alternative medicine , environmental health , pathology , neuropeptide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom